Enhanced plasma insulin response to L-Leucine load and its diminution after weight reduction
1
Citation
0
Reference
20
Related Paper
Cite
Catabolism
Nitrogen balance
Gluconeogenesis
Calorie
Cite
Citations (35)
To test whether, in horses, the concentration of muscle glycogen can be influenced by increasing the uptake of glucose into the muscle cells or by providing a gluconeogenic precursor, 9 trained half-bred riding horses performed on a treadmill a 1.5 h competition exercise test (CET). Each horse performed CET 3 times and 30 min after CET, each was given one of the following solutions: isotonic glucose-electrolyte (GE) solution, GE supplemented with 50 g leucine (GEL) to increase insulin secretion, or GE supplemented with 200 ml propionic acid (GEP), a gluconeogenic precursor. Administration of GE solutions caused no increase in plasma glucose concentration. The highest concentration of insulin was measured after GEL, but also in the GE group the concentration of insulin increased. GEP completely inhibited the increase in insulin concentration. Concentration of glucagon was increased 6 and 22.5 h after CET. None of the post exercise treatments influenced significantly the glycogen content at 22.5 h after CET. This indicates that neither i) elevation of insulin concentration to increase muscle-uptake of glucose, nor ii) increase in the availability of a glucose precursor, propionic acid, was able to increase accumulation of glycogen in the middle gluteal muscle.
Gluconeogenesis
Cite
Citations (42)
Exercising for 3.75 h on a treadmill at 50% VO2 max in the fed state induced an increased excretion of 71 mg nitrogen/kg over the 18 h after exercise. However, measurements of the time course of changes in 13CO2 excretion from ingested [1-13C]leucine indicated that all of this increased nitrogen production occurs during the exercise period. Because of the reduced renal clearance and slow turnover of the urea pool, urea excretion lags behind urea production. Measurements of nitrogen flux from the plateau labeling of urinary ammonia achieved by repeated oral doses of 15N-labeled glycine indicated that the nitrogen loss resulted from an increase in protein degradation and a decrease in protein synthesis. Further studies with [1-13C]leucine indicated that a 2-h treadmill exercise induced an increase in the nitrogen loss from 5.4 to 16 mg . kg-1 . h-1 measured with a primed constant infusion of [1-13C]leucine. This resulted from a fall in whole-body protein synthesis. Glucose given at the rate of 0.88 g . kg-1 . h-1 depressed the rate of whole-body protein degradation and appeared to suppress the exercise-induced increase in nitrogen excretion. When leucine oxidation rates were measured at increasing work rates, a linear relationship between percentage of VO2 max and leucine oxidation was observed up to 89% VO2 max when 54% of the flux of leucine was oxidized. These changes may involve nonmuscle as well as muscle tissue. Thus the source of the increased nitrogen losses is probably liver. In muscle, protein degradation is actually decreased judged by methylhistidine excretion, whereas in liver, protein degradation may be increased. Also the fall in whole-body protein synthesis may reflect changes in nonmuscle tissues because in running rats protein synthesis in muscle is maintained. As far as leucine metabolism is concerned, because the increase in leucine oxidation occurs when leucine and its keto acid concentration falls, exercise must specifically activate the 2-oxoacid dehydrogenase.
Protein turnover
Protein metabolism
Protein Degradation
Treadmill
Cite
Citations (75)
Three different insulin-like effects of growth hormone were studied in segments of adipose tissue obtained from hypophysectomized rats. The onset of each response was preceded by a characteristic lag period: antilipolysis was seen only after a 10-15 minute exposure to growth hormone; stimulation of glucose oxidation was significant 20 minutes after exposure to growth hormone and increased leucine oxidation was seen only after 30 minutes. Each of the responses was measurable without a detectable delay when the tissues were exposed to hormone during a prior incubation period. Accelerated leucine oxidation was detected when 0.01 µg/ml growth hormone was present in the incubation medium; the other responses required a minimum of 0.1 µg/ml. Inhibitors of protein synthesis at concentrations which decreased the incorporation of 14C leucine into protein by 99% had no effect on either the antilipolytic action of growth hormone or the stimulatory action on glucose oxidation, but abolished the acceleration of leucine oxidation. In contrast to findings in diaphragm muscle, theophylline was without effect on any of the insulin-like actions of growth hormone in adipose tissue, even though it decreased the basal rate of glucose and leucine oxidation.
Basal (medicine)
Cite
Citations (30)
RYAN, N. THOMAS Ph.D; GEORGE, BARBARA C. M.D.; EGDAHL, DAVID H.; ECDAHL, RICHARD H. M.D. Author Information
Hemorrhagic shock
Cite
Citations (39)
Increased fetal glucose concentration decreases ovine fetal leucine oxidation independent of insulin
Fetal leucine oxidation rate is elevated during fasting of the ewe. Euglycemic hyperinsulinemia causes the leucine oxidation rate to decline. However, it is unclear whether this is a direct effect of insulin or is secondary to increased insulin-mediated glucose utilization. To better delineate the mechanism of decreased oxidation, we suppressed fetal insulin secretion by somatostatin infusion. Glucose was infused at a variable rate to achieve glucose concentrations 125 and 150% of basal. Leucine rate of appearance (Ra) was determined by infusion of [15N, 1-13C]leucine. Fraction of leucine appearance oxidized was determined by [1-14C]leucine infusion and determination of fetal 14CO2 excretion. Each fetus was studied during ad libitum maternal feeding and after a 5-day complete maternal fast. Changes were noted in fetal leucine oxidation, which declined from 8.4 +/- 1.2 to 5.0 +/- 0.8 mumol/min in the fed state during glucose infusion. Basal leucine oxidation was elevated during fasting (11 +/- 1.5 mumol/min, P < 0.05) and declined to 8.0 +/- 1.4 mumol/min during glucose infusion (P = 0.056). Leucine carbon Ra was unchanged by fasting and by glucose infusion; leucine nitrogen Ra declined in the fed state only. Leucine oxidation was inversely correlated with glucose concentration (oxidation = 12-0.26 x glucose concentration, r = 0.42, P = 0.004). Leucine oxidation was not correlated with insulin concentration (r = 0.2). Changes in fetal glucose concentration may alter the pattern of utilization of essential amino acids, independent of changes in insulin and insulin-mediated glucose utilization rate.
Basal (medicine)
Hyperinsulinemia
Cite
Citations (15)
Role of Basal Insulin in the Regulation of Protein Kinetics and Energy Metabolism in Septic Patients
We have investigated the role of basal insulin concentration on leucine kinetics (determined by means of 1‐[ 13 C]leucine) and energy metabolism (determined by indirect calorimetry) in eight septic patients by reducing insulin (and glucagon) secretion by somatostatin infusion. Basal glucagon concentration was elevated (744 ± 381 pg/mL), and insulin concentration was normal (10 ± 4 μU/mL). Basal resting energy expenditure (REE) was 151 ± 8% that of predicted basal energy expenditure, and leucine appearance (Ra), oxidation, and nonoxidative disposal rates were all elevated above the normal ranges. Somatostatin infusion reduced insulin concentration by 52% and glucagon concentration by 64%. This resulted in a significant increase in the rate of leucine oxidation from 0.96 ± 0.08 to 1.18 ± 0.14 μmol/kg/min ( p < 0.01), and nonoxidative leucine disposal decreased from 2.95 ± 0.18 to 2.67 ± 0.17 μmol/kg/min ( p < 0.01). Somatostatin infusion also caused significant increases in REE and fat oxidation from 1310 ± 100 to 1505 ± 128 kcal/m 2 /day ( p < 0.05) and from 1.72 ± 0.24 to 2.41 ± 0.41 mg/kg/min, respectively, and a slight decrease of carbohydrate oxidation from 1.51 ± 0.49 to 1.31 ± 0.49 mg/kg/min. These metabolic responses can be attributed to the reduction in insulin concentration, because they are in the opposite direction of changes that would occur as a consequence of a reduction in glucagon concentration. We conclude that the basal insulin plays an important role in attenuating net protein loss and energy expenditure. ( Journal of Parenteral and Enteral Nutrition 15 :394–399, 1991)
Basal (medicine)
Cite
Citations (13)
To elucidate the acute metabolic actions of insulin-like growth factor I (IGF-I), we administered a primed (250 micrograms/kg), continuous (5 micrograms/kg.min) infusion of human recombinant (Thr 59) IGF-I or saline to awake, chronically catheterized 24-h fasted rats for 90 min. IGF-I was also infused while maintaining euglycemia (glucose clamp technique) and its effects were compared to those of insulin. IGF-I infusion caused a twofold rise in IGF-I levels and a 75-85% decrease in plasma insulin. When IGF-I alone was given, plasma glucose fell by 30-40 mg/dl (P less than 0.005) due to a transient twofold increase (P less than 0.05) in glucose uptake; hepatic glucose production and plasma FFA levels remained unchanged. IGF-I infusion with maintenance of euglycemia produced a sustained rise in glucose uptake and a marked stimulation of [3-3H]glucose incorporation into tissue glycogen, but still failed to suppress glucose production and FFA levels. IGF-I also produced a generalized 30-40% reduction in plasma amino acids, regardless of whether or not hypoglycemia was prevented. This was associated with a decrease in leucine flux and a decline in the incorporation of [1-14C]leucine into muscle and liver protein (P less than 0.05). When insulin was infused in a dosage that mimicked the rise in glucose uptake seen with IGF-I, nearly identical changes in amino acid metabolism occurred. However, insulin suppressed glucose production by 65% and FFA levels by 40% (P less than 0.001). Furthermore, insulin was less effective than IGF-I in promoting glycogen synthesis. We conclude that (a) IGF-I produces hypoglycemia by selectively enhancing glucose uptake; (b) IGF-I is relatively ineffective in suppressing hepatic glucose production or FFA levels; and (c) IGF-I, like insulin, lowers circulating amino acids by reducing protein breakdown rather than by stimulating protein synthesis. Thus, IGF-I's metabolic actions in fasted rats are readily distinguished from insulin.
Carbohydrate Metabolism
Cite
Citations (294)
We have previously hypothesized that increased muscle oxidation of leucine in starvation is an adaptive response to fuel deficiency in this tissue. To investigate this hypothesis further, we have measured the rates of oxidation, turnover, and plasma clearance of [1-14C]leucine in six obese subjects at rest and during 2 h of mild leg exercise. This experimental design was based on the fact that exercise has the greatest impact on energy expenditure in muscle, the principal site for leucine oxidation. Exercise produced a fourfold increase in oxygen consumption. The rate of alpha-decarboxylation of leucine was increased twofold by leg exercise, whereas there were modest decreases (13%) in the rates of turnover and plasma clearance of this amino acid. The plasma concentrations of lactate and alanine increased twofold during exercise, but plasma concentrations of leucine and other amino acids, glucose, beta-hydroxybutyrate, and insulin remained unaltered. Our data suggest that during exercise oxidation of leucine as an energy source increases, whereas the utilization of this amino acid as a substrate for protein synthesis decreases.
Alanine
Protein turnover
Gluconeogenesis
Decarboxylation
Cite
Citations (54)